https://www.clinicaltrialsarena.com/news/immuneering-solid-tumour-trial/
Immuneering has dosed the first subject in its Phase I/IIa trial of IMM-6-415 for the treatment of solid tumours with genetic mutations.
first subjectsolid tumourdosesphaseiia
https://www.clinicaltrialsarena.com/news/enlivex-solid-tumour-trial/
Enlivex Therapeutics has received approval from the Israeli MOH to begin a Phase I/II trial of Allocetra in advanced solid tumour patients.
solid tumourreceivesapprovalphaseii
https://www.clinicaltrialsarena.com/news/hutchmed-solid-tumours/
HUTCHMED has dosed the first patient in its Phase I study of HMPL-415 to treat advanced malignant solid tumours in China.
solid tumourdosesfirstpatienttherapy